DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Gan HK, Fichtel L, Lassman AB. et al.
A phase 1 study evaluating ABT-414 in combination with temozolomide (TMZ) for subjects with recurrent or unresectable glioblastoma (GBM).
J Clin Oncol 2014;
32 (Suppl. 05) abstr 2021
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.